/CNW/ - bioMérieux, a world leader in the field of in vitro diagnostics, announces the acquisition of LUMED, a software company that has developed a clinical ...

Regulatory News: bioMérieux (Paris:BIM), a global player in in vitro diagnostics and world leader in food microbiology testing, today announced the ac ...

NucliSENS EasyQ MRSA complements chromID™ MRSA, bioMérieux’s chromogenic media, which enables direct, color-specific visual observation of the bacterial colonies in patient samples ...

McKesson Medical-Surgical Inc., an affiliate of the McKesson Corporation, has signed an exclusive agreement with bioMérieux, Inc. to serve the U.S. co ...